Photo by nci from unsplash
Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care for patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI) with stenting, but is associated… Click to show full abstract
Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care for patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI) with stenting, but is associated with high bleeding risk. The RE-DUAL PCI multicentre trial ([NCT02164864][1])
Keywords:
consequences cardiovascular;
bleeding events;
events readmission;
events consequences;
readmission net;
cardiovascular events
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!